Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UK Innovation & Science Seed Fund (UKI2S) is a specialized venture capital fund focused on early-stage companies emerging from the UK's publicly funded research base. While not a drug development company itself, it is a critical player in the UK life sciences ecosystem, providing seed-stage investment to high-risk, high-reward biotech, healthcare, and deep-tech startups. The fund is backed by UK Research and Innovation (UKRI) and other public bodies, aiming to bridge the gap between academic research and commercial viability. UKI2S manages a diverse portfolio of companies across therapeutics, diagnostics, and medical devices, often acting as the first institutional investor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UK Innovation.